BioSpace News Archive

Surgalign Holdings, Inc. announced that it has granted restricted stock unit awards to eleven employees, none of whom are executive officers, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 543,380 shares of Surgalign common stock.

NeuroOne Medical Technologies Corporation announced that, effective March 1, 2022, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan, as a material inducement to an individual entering into employment with the Company.

Albany NY, United States: Adrenergic drugs, also called as sympathomimetic drugs, are the medication used to stimulate the sympathetic nervous system located in several parts of the body such as the chest and lower back region of the spinal cord.

Albany NY, United States: The global blood glucose monitoring devices market is likely to be driven by the rising prevalence of diabetes, as well as the growing elderly population, which are prone to diabetes.

Albany NY, United States: Dendritic cells are known as accessory cells of the mammalian immune system. Their major function is to process surface antigen of T cells of immune system.

The rising disposable income of people around the world is promoting a shift from conventional to advanced wound care products, which in turn is providing a significant push to the global medical foam market.

On February 23, 2022 , 111, Inc. (“111" or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, signed a strategic cooperation agreement on direct supply with Xi’an Beilin Pharmaceutical Co., Ltd.

Arvinas, Inc. today announced that it will participate in two upcoming virtual investor conferences: Cowen & Co. 42nd Annual Health Care Conference on Monday, March 7.

Anavex Life Sciences Corp. today announced that it has changed its auditors from BDO USA LLP (“BDO“) to Grant Thornton LLP.

Cardiovascular Systems, Inc. today announced that it has appointed Jeffery W. Chambers, M.D., as Chief Medical Officer.